RARA and acute myeloid leukemia: Downregulation of hTERT expression following retinoid treatment has also been observed in maturation-resistant APL cell lines and non-APL AML cell lines, but in these cell lines cotreatment with a specific RARα agonist and a retinoid X receptor- (RXR-) specific agonist (a rexinoid) was required.